Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.


Güner A., Kalçik M., Aykan A. Ç., Gürsoy M. O., Kalkan A. K., Astarcioğlu M. A., ...Daha Fazla

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, cilt.31, ss.536-542, 2020 (SCI-Expanded, Scopus)